Lukong lab - Cancer Treat Res Commun paper

Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors

Kim N, Lukong KE. Cancer Treat Res Commun. 2026 Feb 7;47:101134. doi: 10.1016/j.ctarc.2026.101134. Online ahead of print. PMID: 41678931